Clinical Trial Update: Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term maintenance of effect of Sativex in adults with spasticity due to multiple sclerosis; completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Spasticity

Drugs mentioned

• Sativex (nabiximol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Spasticity, Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2011-06-17